Incidence of Hemolysis in Patients with Cardiogenic Shock Treated with Impella Percutaneous Left Ventricular Assist Device
Impella assist devices have been increasingly used in cardiogenic shock (CS).
You may also like
Extracorporeal Membrane Oxygenation Support in 2019 Novel Coronavirus Disease: Indications, Timing, and Implementation
Because the evidence for recovering from COVID-19 with ECMO is extremely limited so far, we can learn from the previous experiences in the treatment of similar severe viral pneumonia cases through retrospective literature review and data analysis.
Comparative Analysis of the Benefits of Autotransfusion of Blood by a Shed Blood Collector After Total Knee Replacement
INTRODUCTION. Joint replacement is associated with massive blood loss. Various techniques have been used to avoid the use of allogeneic blood. One […]